3.25% until 31mar26 3.25% until 31mar26 (BE0002777580)

Good to know because I was thinking about letting it go but now I have a reason to hold

This is by far the Best piece Gary has written imho

https://garywallach.substack.com/p/from-qualification-to-harvest-could?r=3iu9hl&utm_campaign=post&utm_medium=web&triedRedirect=true

I doubt you will agree or bother reading what I have said but at least it wasn’t written by some AI.
I have read it all and you are right... I don't agree with ANY of it.

No, I don't believe they have done EVERYTHING right... But I do believe that had it been any other CEO...

Stay away stay very far away........

I’m busy today, but these results are in line with what I expected. Excellent, and very helpful for all current and potential stakeholders. For current therapy as well as future improvements with combination therapy. Happy 4th Tomorrow!

Ok, This Explains it. I didn't know which Wall St (Or elsewhere in Europe like James St) Scoundrel "Creditors' were "Filing TWICE or even More' to get their Money from multiple Lehman Entities ..Frankly, those SCUM should be prosecuted for Fraud and Thrown in Jail for Good...

They didn't go to Europe. They're already there. It's an Italian company! Y90 has no shelf life. To do a trial outside of manufacturing continent is a complete waste of time, as RDGL has well demonstrated already. One company has competent leadership and one doesn't. One company is over 4 year

What're you waiting for ?......

Drink

https://investorshub.advfn.com/uimage/uploads/2026/7/3/eg[hqgutsi_group_for_health_logo.jpg

.

I believe it was published by a standard member, right after the microcap club conference in June. I'm hoping that will help get a lot more eyes on it.

flipper44,

Thanks for explaining this. Just to be clear for others, you are describing OS as an absolute number (can’t change) from the data in the trial. The comparator number is what can change based on the methods utilized to measure SOC/placebo benefit. This difference in measu

The interesting thing was the companies that thought Elite was too big for them to purchase. Makes me think that the acceptable sale price is significantly higher than where we are now. I’d like to know the number they have in mind.

The Scam is getting called out by alot of the bagholders now, eh? PUMP and DUMP city is where your at. The Path is south. Typical OTC lies and rumors. SUB 12 and that's being very nice!

Once could hope that conclusion would be worth a 💯 pop in price on Monday.

But LP will make sure the faucet is on at .20

I’m kind of wondering if they’re just going to use Williams compressor station that’s where that 42 inch line goes to.

Baffling indeed bruvs

Limited independent sampling activities conducted during Phase 1 detected the presence of certain precious metals in the samples analyzed, consistent with metals identified in the historical analytical data.

Schappert found no gold. None. Zero.

Let that sink in a bi

$KARX -Karbon-X Corp offers investors exposure to VERRA Certified carbon credits which are a keyinstrument used by both individuals and corporations to achieve their carbon neutral and net-zero carbon goals. The company is environmental and social governance (ESG) principled and focuses on partnerin

$KARX -Karbon-X Corp offers investors exposure to VERRA Certified carbon credits which are a keyinstrument used by both individuals and corporations to achieve their carbon neutral and net-zero carbon goals. The company is environmental and social governance (ESG) principled and focuses on partnerin

Hmm... What are you saying Cotton?

So, 10-B CT Claims 'Have been Satisfied in FULL'? When? Because, LBHI 'internally made some Accounting Entries of the distributions to 10-B CTs' and then "Re-directed them UP' to Higher Sr. Creditors???

TIA & GLTU!

See post this replies to (yeowch)

https://investorshub.advfn.com/uimage/uploads/2026/7/3/jhzuocco_july_3_2y_suspend_oval_sma.png

Public biotech companies are not required to publish at-the-market (ATM) equity sales at the exact time of the transaction.

One of the main reasons biotech firms favor ATM programs is this delayed visibility, which allows them to quietly raise capital without alerting the broader mar

Results just post on X by Andrew Caravello, DO

Happy 4th Uts---just a note--you can enter a lineup at any point during the tourney if you miss the start and you will accrue points for all subsequent rounds----specifically, in this case, you can enter a team before the 3rd round starts tomorrow and you will get the points for the 3rd and 4th roun

It’s time for a manufacturing update and I will continue to harp on this until it is given since 1.5 years were wasted last time by lack of proper oversight. I guess we were given a clue when Dr Shashi Murthy left the scene. Best wishes.


I genuinely appreciate you’re being wi